Medexus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 19 Sep 24 | Buy€4,963 | Kenneth d'Entremont | Individual | 3,000 | €1.65 | |
| 26 Aug 24 | Buy€8,108 | Brendon Buschman | Individual | 5,000 | €1.62 | |
| 28 Jun 24 | Buy€7,330 | Kenneth d'Entremont | Individual | 6,000 | €1.23 | |
| 28 Jun 24 | Buy€17,875 | Brendon Buschman | Individual | 15,000 | €1.19 | |
| 13 Feb 24 | Buy€3,721 | Benoit Gravel | Individual | 3,200 | €1.16 |
Insider Trading Volume
Insider Buying: P731 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 1,987,483 | 8.06% |
| Individual Insiders | 2,362,221 | 9.58% |
| General Public | 20,302,789 | 82.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1,477,733 | €2.4m | 0.67% | no data | |||
| 1,038,716 | €1.7m | 0% | 40.93% | |||
| 812,000 | €1.3m | -47.1% | 0.03% | |||
| 554,280 | €890.7k | 1.32% | no data | |||
| 135,100 | €217.1k | 0% | 0.12% | |||
| 97,070 | €156.0k | 8.01% | no data | |||
| 66,053 | €106.1k | 20.1% | no data | |||
| 63,532 | €102.1k | 12.7% | no data | |||
| 24,412 | €39.2k | 84.1% | no data | |||
| 24,412 | €39.2k | 84.1% | no data | |||
| 22,942 | €36.9k | 15.6% | no data | |||
| 20,634 | €33.2k | 0% | no data | |||
| 11,153 | €17.9k | 0% | no data | |||
| 1,667 | €2.7k | 0% | 100.0% |